ORCL

Sale of shares pursuant to Rule 10b5-1 Plan adopted on January 2, 2026.

This transaction was executed in multiple trades at prices ranging from $164.56 to $165.45. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Sale of shares pursuant to Rule 10b5-1 Plan adopted on January 2, 2026.

This transaction was executed in multiple trades at prices ranging from $156.50 to $157.48. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Sale of shares pursuant to Rule 10b5-1 Plan adopted on January 2, 2026.

This transaction was executed in multiple trades at prices ranging from $162.53 to $163.40. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Sale of shares pursuant to Rule 10b5-1 Plan adopted on January 2, 2026.

This transaction was executed in multiple trades at prices ranging from $157.50 to $158.49. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Sale of shares pursuant to Rule 10b5-1 Plan adopted on January 2, 2026.

Sale of shares pursuant to Rule 10b5-1 Plan adopted on January 2, 2026.

This transaction was executed in multiple trades at prices ranging from $155.50. to $156.49. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Exercise of stock option pursuant to Rule 10b5-1 Plan adopted on January 2, 2026.

25% of the shares subject to the option vested annually on each anniversary of the grant date.

Sale of shares pursuant to Rule 10b5-1 Plan adopted on January 2, 2026.

This transaction was executed in multiple trades at prices ranging from $161.53 to $162.51. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Sale of shares pursuant to Rule 10b5-1 Plan adopted on January 2, 2026.

This transaction was executed in multiple trades at prices ranging from $160.50 to $161.47. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Exercise of stock option pursuant to Rule 10b5-1 Plan adopted on January 2, 2026.

Sale of shares pursuant to Rule 10b5-1 Plan adopted on January 2, 2026.

This transaction was executed in multiple trades at prices ranging from $163.55 to $164.50. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Sale of shares pursuant to Rule 10b5-1 Plan adopted on January 2, 2026.

This transaction was executed in multiple trades at prices ranging from $159.50 to $160.49. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Sale of shares pursuant to Rule 10b5-1 Plan adopted on January 2, 2026.

This transaction was executed in multiple trades at prices ranging from $158.50 to $159.49. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Restricted stock units vest 100% on first anniversary of grant date.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Restricted stock units vest 100% on first anniversary of grant date.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Restricted stock units vest 100% on first anniversary of grant date.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Restricted stock units vest 100% on first anniversary of grant date.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Restricted stock units vest 100% on first anniversary of grant date.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Restricted stock units vest 100% on first anniversary of grant date.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Restricted stock units vest 100% on first anniversary of grant date.

Shares withheld for payment of tax liability upon vesting of restricted stock units.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Restricted stock units vest 100% on first anniversary of grant date.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Restricted stock units vest 100% on first anniversary of grant date.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Restricted stock units vest 100% on first anniversary of grant date.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Restricted stock units vest 100% on first anniversary of grant date.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Restricted stock units vest 100% on first anniversary of grant date.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Restricted stock units vest 100% on first anniversary of grant date.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Shares withheld for payment of tax liability upon vesting of restricted stock units.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

Restricted stock units vest 100% on first anniversary of grant date.

Each restricted stock unit represents the right to receive, at settlement, one share of common stock.

The shares subject to the restricted stock units will vest as to 40% on May 5, 2027, 30% on May 5, 2028, 20% on May 5, 2029 and 10% on May 5, 2030, subject to the Reporting Person's continued employment through each applicable vesting date

The shares subject to the stock options will vest as to 40% on May 5, 2027, 30% on May 5, 2028, 20% on May 5, 2029 and 10% on May 5, 2030, subject to the Reporting Person's continued employment through each applicable vesting date

Represents dividend equivalents accrued with respect to earned restricted stock units that were granted on November 5, 2022, which the reporting person has elected to defer. The number of dividend equivalents reported was calculated using Oracle's closing stock price on April 24, 2026 ($173.28), the date on which dividends were paid on Oracle's common stock.

On April 16, 2026, the reporting person transferred 745,000 shares of common stock from the Jeffrey & Judy Henley 1989 Trust to a newly created grantor retained annuity trust of which the reporting person is the trustee.

On April 16, 2026, the reporting person transferred 745,000 shares of common stock from the Jeffrey & Judy Henley 1989 Trust to a newly created grantor retained annuity trust of which the reporting person is the trustee.

Sale of shares pursuant to Rule 10b5-1 Plan adopted on January 13, 2026.

On March 30, 2026, the reporting person transferred 128,304 shares of common stock from his 2024 GRAT to the Henley Community Property Trust. The reporting person believes that this transfer of shares constitutes a change in form of beneficial ownership of the shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934.

On March 30, 2026, the reporting person transferred 128,304 shares of common stock from his 2024 GRAT to the Henley Community Property Trust. The reporting person believes that this transfer of shares constitutes a change in form of beneficial ownership of the shares, exempted by Rule 16a-13 under the Securities Exchange Act of 1934.

This transaction was executed in multiple trades at prices ranging from $155.23 and $155.28. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.

Represents dividend equivalents accrued with respect to earned restricted stock units that were granted on November 5, 2022, which the reporting person has elected to defer. The number of dividend equivalents reported was calculated using Oracle's closing stock price on January 23, 2026 ($177.16), the date on which dividends were paid on Oracle's common stock.

Sale of shares pursuant to Rule 10b5-1 Plan adopted on October 9, 2025.

Includes 46 shares acquired under the Issuer's employee stock purchase plan on September 30, 2025.

This transaction was executed in multiple trades at prices ranging from $196.87 and $196.93. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transaction was effected.